Bremelanotide is FDA-approved for lipodystrophy and a rare genetic condition involving hypopigmentation and morbid obesity.

“It's also approved for lipodystrophy, which is the same exact thing as tesamorelin, which I believe is also known as Evista or Egrifta. And then it's also approved for the rare genetic condition where your receptors or your melanocytes don't proliferate as well, so you usually have hypopigmentation. It's not true albinism, but it's associated with morbid obesity and very be poor outcomes from that in childhood, so it's used in kids actually.”